Trial Profile
Gonadotropin Releasing Hormone Antagonist in Treatment of Early-onset Severe Ovarian Hyperstimulation Syndrome - a Randomized Controlled Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Cetrorelix (Primary)
- Indications Ovarian hyperstimulation syndrome
- Focus Therapeutic Use
- 11 Jun 2016 New trial record